Myeloma 2016: Panel discussion on gene modified T-cells
Edward Stadtmauer et al.
Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
What we can look forward to in the world of non-Hodgkin lymphoma
Myeloma 2016: Panel discussion on the new treatment paradigm
Gareth Morgan et al.
Novel therapies for the treatment of CLL, MCL and FL
Nathan Hale Fowler